ADME DRIVE
Live / Registered — Registered (as of 24 Mar 2026)
What this means for you
Registered since 24 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98212709
- Registration number
- 8188369
- Mark type
- Stylized text
- Filed
- 06 Oct 2023
- Published for opposition
- 09 Jul 2024
- Registered
- 24 Mar 2026
- Attorney of record
- Gregory B. Coy
Goods and services
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines
Owner
- Superluminal Medicines, Inc., Boston, MA, US
- Superluminal Medicines, Inc., Boston, MA, US
- Superluminal Medicines, Inc., Boston, MA, US
Prosecution history
- 24 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 04 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Feb 2026 — ASSIGNED TO LIE
- 19 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Jan 2026 — NON-FINAL ACTION E-MAILED
- 20 Jan 2026 — SU - NON-FINAL ACTION - WRITTEN
- 17 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED